Floatz logo

m701 pleural infusion

Malignant Pleural Effusions

Wuhan YZY Biopharma Co., Ltd.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Malignant Pleural Effusions cohort.

Asset / SponsorPhaseRating
Zactima
M.D. Anderson Cancer Center
Phase 2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Wuhan YZY Biopharma Co., Ltd.
Phase 1/2CCC
Photofrin II
Roswell Park Cancer Institute
Phase 1CC
Wsk-Im02
WestVac Biopharma Co., Ltd.
Phase 1CC

Same molecule, other indications

m701 pleural infusion is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →